Poisoning by colchicine may occur following ingestion of this alkaloid used for the treatment of acute gouty arthritis. The authors report two fatalities and describe a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS-MS) triple-quadrupole method for the determination of colchicine in autopsy samples. One milliliter of heart blood, femoral blood, urine, bile, gastric, and vitreous each were extracted with saturated NH4CI at pH 9.6 and dichloromethane/5% isopropanol. Separation was achieved on a C18-Xterra column with a mobile phase consisting of 2ram ammonium formate buffer (pH 3)/acetonitrile in a gradient mode. Four product ions of the protonated molecule were monitored. The method was fully validated in whole blood (1 mL) and was linear in the range of 0.5-50 ng/mL (r 2 > 0.99). The limit of detection was 0.1 ng/mL (50 times S/N), and the limit of quantitation was 0.5 ng/mL with RSDs < 11.8% intraday (n = 6), < 18.7% interday (n = 18), and accuracy < 3% (n = 18). Case #1: a 33-year-old nurse committed suicide by the ingestion of 80 colchicine 1-rag tablets. She died 61 h later after resuscitation procedures. Colchicine was found in heart blood at 5.2 ng/mL, femoral blood at 17.4 ng/mL, urine at 19.4 ng/mL, bile at 42.8 ng/rnL, gastric at 348 ng/mL, and vitreous at 3 n~mL. Case #2: a 57-year-old man with gout was found dead at home. Colchicine was found in heart blood at 22.8 ng/mL, femoral blood at 21.9 ng/mL, lung blood at 45.2 ng/mL, urine at 148.5 ng/mL, bile at 1818.5 ng/mL, gastric at 219.8 ng/mL, and vitreous at 0.5 ng/mL. These results were consistent with death. Because of its good sensitivity, this LC-ESI-MS-MS triple-quadrupole method is suitable for the determination of colchicine not only in fatalities but also for pharmacokinetic studies.
Introduction
Colchicine ( Figure 1 ) is a natural toxic alkaloid of Colchicum genera from Liliaceae and is found in Colchicum autumnale.
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Colchicine is obtained from the corm and seeds of the meadow saffron and other Colchicum species. It is mainly used for the treatment of acute gouty arthritis and for the prophylaxis of acute attacks. The treatment of acute gouty arthritis is relatively well cured by the use of colchicine as anti-inflammatory agent to urate crystals. The mechanism is not well-known and may be due to several actions (inhibition of leucocytes mobility and activity) (1) . Colchicine also inhibits cellular mitosis by binding to tubulin and is used in the treatment of cancer. It has also been used for the treatment of amyloid deposition in familial Mediterranean fever, and primary biliary cirrhosis (2) .
Colchicine was first isolated in 1820 by French chemists Joseph Pelletier and Joseph-Bienaim~ Caventou. Colchicum autumnale is widely encountered in all Europe and may be mistaken for Crocus or wild garlic. This confusion leads to severe intoxications mainly in Turkey on "Crocus Day" and in Eastern Europe.
Colchicine is generally given by oral route as tablets. After ingestion, colchicine is quickly absorbed by the gastrointestinal tract. Peak plasma concentrations of colchicine are reached within I h and are in the range of 4.0 to 7.6 ng/mL after a l-rag dose, with an average peak of 5.5 ng/mL. Steady-state serum concentrations are about 0.3 to 2.4 ng/mL (1,2). Its half-life is O'~ CH3
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quite long (about 23--41 h), but concentrations fall quickly in the first 30 rain after ingestion (3). Colchicine is fixed on many tissues, except for the myocardium, lungs, and skeletal muscles. The main way of metabolism is a deacetylation of the molecule in the liver. Then, the metabolites turn over to enterohepatic circulation before being excreted into the bile (10 to 25%) and the feces (10 to 56% after oral administration). The urinary excretion is about 10 to 20% of the administered dose (2) . In normal subjects, about 28% of the administered dose remained in unchanged form (3) .
The most frequent adverse effects of oral colchicine are those involving the gastrointestinal tract and may be associated with its antimitotic action (2) . Symptoms of toxicity occur after several hours and are commonly nausea, vomiting, and diarrhea. Multiple organ failure, hemorrhage, bone marrow depression, muscle damage, respiratory distress, and myocardial injury are observed after overdosage. Death may be due to respiratory depression, cardiovascular collapse, or bone marrow depression (2) .
Because of its narrow therapeutic range in daily therapy, very low concentrations have to be detected. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) seemed to be the most suitable analytical technique for the determination of colchicine in biological fluids.
Experiment
Standards and reagents
Pure colchicine was obtained from Sigma France. Clonazepam-d4 was obtained from Cerilliant (Promochem France). Ammonium formate (rain 98%), formic acid (99%), ammonium chloride, ammonia solution 30%, acetonitrile (HPLC grade RS Plus), and methanol for analysis were obtained from Carlo Erba France. Dichloromethane (Chromanorm HPLCgrade) was obtained from Prolabo France. Isopropanol (2-propanol) was obtained from Merck France.
Extraction procedure
Peripheral blood obtained from donors without colchicine treatment was used for the preparation of standards for the validation step. Standard blood samples were spiked with methanolic solutions of colchicine. Biological fluids (1 mL each) were extracted with 1 mL saturated NH4CI and adjusted to pH 9.6 with ammonia and 5 mL dichloromethane with 5% 2-propanol. Ten nanograms of clonazepam-d4 was added as internal standard (IS) before extraction. After 10-rain agitation, the tubes were centrifuged for 5 min at 3500 rpm. The organic layer was transferred into glass tubes then evaporated under a gentle stream of nitrogen at 45~ The residues were reconstituted in 75 IJL methanol, and transferred into vials for analysis by LC-MS-MS.
Ten microliters was injected into the chromatographic system.
Apparatus
The LC separation was carried out using a Thermo Electron Surveyor system, fitted with a ClrXterra column (3.5 IJm, 150 x 2 mm, Waters, France). The mobile phase consisted of a mixture of acetonitrile and 2raM formate buffer (pH 3). It was delivered at a flow rate of 200 IJL/min, under the following conditions: 20:80 (v/v) held I min, then increased to 90:10 (v/v) up to 10 rain, and re-equilibrated for 5 rain at initial conditions.
The detection was performed on a triple-stage quadrupole (TSQ Quantum Ultra, Thermo Electron, France) with an electrospray ionization (ESI) probe (Ion Max, Thermo Electron) in positive polarity mode.
For the optimization of detection conditions, direct infusions of standard solutions (10 !Jg/mL) were done using a T connection with mobile phase at a flow of 100 tJL/min. Best resuits were obtained with a spray voltage of 4500 V and a capillary temperature at 360~ Sheath gas pressure, auxiliary, and sweep gas flow were optimized, respectively, at 30, 5, and 5 (arbitrary units). Collision cell pressure was set at 1.5 mTorr of argon. Fragmentation of the protonated molecules and multiple reaction monitoring (MRM) of daughter ions were performed with a scan time of 0.1 s and a width of _+ 0.5 a.m.u. Collision energies were optimized for a maximum detection of each daugther ion for colchicine and clonazepam-d4. (See Table  I .) The total ion current (TIC) of daughter ions for both molecules was used for quantification.
An accuracy of less than 20% was expected on relative abundances of daughter ions of colchicine for the limit of quantification (LOQ) with a relative standard deviation of less than 25% interday.
Results
The method was fully validated in blood and results are summarized in Table II . The linearity was studied over the concen- The target concentration defined as the limit of detection (LOD) was 0.1 ng/mL (1 mL of blood spiked with 10 IJL of colchicine at 10 ng/mL). Injections were carried out in order to confirm the detection of the colchicine. Despite some variations in the proportion of characteristic daughter ions for colchicine, the LOD was estimated at 0.1 ng/mL [50 times the signal-to-noise ratio (S/N) and 4 daughter ions]. The other parameters, such as the analytical absence of interference of the system and of blank matrix, as well as the detection of the four daughter ions at the retention time awaited, freed us from any uncertainty as to the nature of the peak observed at this level.
The LOQ was at 0.5 ng/mL (Figure 2 ) with good relative standard deviations intraday (< 11.8%, n = 6) and interday (< 18.7%, n = 18) and an excellent accuracy (< 3%, n = 18).
Extraction recoveries were determined in whole blood at 0.5 and 10 ng/mL (n --3) by calculating the ratio of the response of colchicine when added before and after extraction, just before the evaporation step. Recoveries were 74.9% and 69.5%, respectively. Recoveries were not determined for other autopsy samples than blood.
Ion suppression phenomenon was studied on blood by the injection of 10 different extracts, with postcolumn infusion of colchicine and internal standard solutions at 1 IJg/mL and a flow rate of 5 IJL/min. No signal loss was observed on the whole chromatogram and particularly at the retention times of colchicine (8.5 rain) and IS (10.6 rain).
Comparison of our LOD and LOQ values with those obtained by other published methods is shown in Table III .
Case sample results
Case #1. A 33-year-old nurse committed a suicide in a psychiatric hospital by ingesting 80 colchicine tablets, which were not prescribed for her. She presented to the emergency department of another hospital and died of cardio-respiratory arrest after intensive care 61 h later. Multiple organ failure was reported at the autopsy. Analysis of postmortem samples showed the presence of colchicine in heart blood at 5.2 ng/mL, femoral blood at 17.4 ng/mL, urine at 19.4 ng/mL, bile at 42.8 ng/mL, gastric at 348 ng/mL, and vitreous at 3 ng/mL.
Case #2. A 57-year-old man with gouty arthritis under longterm treatment committed suicide by ingesting of an unknown quantity of 1-mg colchicine tablets. He was found dead at home by his wife. Concentrations found in autopsy samples were as follows: cardiac blood at 22.8 ng/mL, femoral blood at 21.9 ng/mL, lung blood at 45.2 ng/mL, urine at 148.5 ng/mL, bile at 1818.5 ng/mL, gastric at 219.8 ng/mL, and vitreous at 0.5 ng/mL. 
Discussion
Our LOD and LOQ values obtained from only 1 mL of whole blood were better than those previously described by LC-MS-MS-ion trap in plasma, by LC-diode-array detection .,= E-=2 (LC-DAD) in blood, and by LC-MS (SIM mode) in plasma (Table tII) .
Colchicine peripheral blood concentrations observed in Case #1 (17.4 ng/mL) and Case #2 (21.9 ng/mL) were much higher than therapeutic concentration range (0.3-2.4 ng/mL). These findings clearly demonstrated that colchicine overdosage was the cause of death in both cases.
Among poisoning case reports, only a few publications made a complete state of the concentrations found in other than blood autopsy samples. Data on urine, liver, vitreous, lung, and bile concentrations are scarce. The data resumed in Table  IV were obtained from relatively recent publications (1997 through 2005) (4-10). Generally, colchicine is more easily detected in bile and urine, where it is present in higher levels.
It was interesting to compare our results to those already published in the literature for coichicine poisoning. In Case #1, the blood concentration could appear weak with regards to the quantity ingested (80 tablets is 80 times the therapeutic amount), but the victim died 61 h after admission to the hospital and after intensive care treatment. The concentration in the bile was also weak compared to the data previously published (see Table IV ). However, the majority of the cases published concerned patients undergoing colchicine treatment. In those cases, intestinal reabsorption (1) and the long half-life of colchicine led to an increase in the concentration of this molecule in bile compared to those expected after single intake. In Case #1, the victim was not undergoing colchicine treatment, and this may be an explanation for the relatively weak concentration of colchicine in bile. Thus, a high concentration in the gastric content associated with a weak concentration in bile compared to some other publications about colchicine fatalities could be characteristic of an acute intoxication by ingestion of colchicine outside any therapeutic treatment.
In Case #2, the high bile concentration found for this patient under long-term colchicine treatment illustrated the importance of intestinal reabsorption of colchicine.
We noticed a peripheral-to-cardiac blood ratio of 3.3 in Case #1 after intensive care. This was previously described in the literature (4) and we supposed that it may be in connection with a cardiac massage before death, with a phenomenon of evacuation of cardiac blood towards peripheral vessels. Moreover, colchicine is not strongly fixed in the myocardium.
Review of the literature from 1997 through 2005 showed many publications about colchicine poisoning, and among them many are fatalities. A total of 47 case reports of poisoning have been reported, and death occurred in 93.6% of the case. They could be categorized by five types (Table V) : homicides (n = 2), accidental poisoning (n = 5), plant mix-up (n = 11), suicides (n ---7), and inappropriate intravenous administration dosage (n = 22), which was only reported in the United States (intravenous use of colchicine is actually not allowed in France) and was mainly due to the narrow therapeutic range of colchicine.
Conclusions
Determination of peripheral blood concentration of colchicine is essential for forensic reports. Indeed, even though colchicine is more easily detectable in urine and bile, the cause of death cannot be assessed by a urinary concentration only and, because of intestinal reabsorption, the concentration of colchicine in bile cannot be a reference value.
We believe that LC with triple-stage quadrupole tandem MS is a prerequisite for the sensitive and specific determination of colchicine in whole blood and other biological fluids. This technique is also powerful for the determination of other numerous plant poisons, as previously described (11) .
Because of its good sensitivity with low sample amount needed (1 mL), the presented analytical method is suitable for the determination of colchicine in fatalities and pharmacokinetic studies.
